Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & EnergyDetailed TOC of Global Facial Injectables Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
1 Report Overview1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Facial Injectables Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Botox
1.2.3 Dermal Fillers
1.2.4 Other
1.3 Market Segment by Application
1.3.1 Global Facial Injectables Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Cosmetic Centers
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Facial Injectables Market Size (2017-2028)
2.1.1 Global Facial Injectables Revenue (2017-2028)
2.1.2 Global Facial Injectables Sales (2017-2028)
2.2 Global Facial Injectables Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Facial Injectables Sales by Regions (2017-2022)
2.2.2 Global Facial Injectables Revenue by Regions (2017-2022)
2.3 Global Facial Injectables Market Size Forecast by Region
2.3.1 Global Facial Injectables Sales Forecast by Region (2023-2028)
2.3.2 Global Facial Injectables Revenue Forecast by Region (2023-2028)
2.4 Global Top Facial Injectables Regions (Countries) Ranking by Market Size
2.5 Facial Injectables Market Dynamics
2.5.1 Facial Injectables Market Trends
2.5.2 Facial Injectables Market Drivers
2.5.3 Facial Injectables Market Challenges
2.5.4 Facial Injectables Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Facial Injectables Manufacturers by Sales (2017-2022)
3.1.1 Global Facial Injectables Sales by Manufacturers (2017-2022)
3.1.2 Global Facial Injectables Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Facial Injectables Sales in 2021
3.2 Global Top Manufacturers Facial Injectables by Revenue
3.2.1 Global Facial Injectables Revenue by Manufacturers (2017-2022)
3.2.2 Top Facial Injectables Manufacturers Covered: Ranking by Revenue
3.2.3 Global Facial Injectables Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Facial Injectables Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Facial Injectables as of 2021)
3.4 Global Facial Injectables Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Facial Injectables Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Facial Injectables Market
3.7 Key Manufacturers Facial Injectables Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Facial Injectables Market Size by Type
4.1 Global Facial Injectables Historic Market Review by Type (2017-2022)
4.1.1 Global Facial Injectables Sales Market Share by Type (2017-2022)
4.1.2 Global Facial Injectables Revenue Market Share by Type (2017-2022)
4.1.3 Facial Injectables Price by Type (2017-2022)
4.2 Global Facial Injectables Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Facial Injectables Sales Forecast by Type (2023-2028)
4.2.2 Global Facial Injectables Revenue Forecast by Type (2023-2028)
4.2.3 Facial Injectables Price Forecast by Type (2023-2028)
5 Global Facial Injectables Market Size by Application
5.1 Global Facial Injectables Historic Market Review by Application (2017-2022)
5.1.1 Global Facial Injectables Sales Market Share by Application (2017-2022)
5.1.2 Global Facial Injectables Revenue Market Share by Application (2017-2022)
5.1.3 Facial Injectables Price by Application (2017-2022)
5.2 Global Facial Injectables Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Facial Injectables Sales Forecast by Application (2023-2028)
5.2.2 Global Facial Injectables Revenue Forecast by Application (2023-2028)
5.2.3 Facial Injectables Price Forecast by Application (2023-2028)
6 North America
6.1 North America Facial Injectables Sales Breakdown by Company
6.1.1 North America Facial Injectables Sales by Company (2017-2022)
6.1.2 North America Facial Injectables Revenue by Company (2017-2022)
6.2 North America Facial Injectables Market Size by Type
6.2.1 North America Facial Injectables Sales by Type (2017-2028)
6.2.2 North America Facial Injectables Revenue by Type (2017-2028)
6.3 North America Facial Injectables Market Size by Application
6.3.1 North America Facial Injectables Sales by Application (2017-2028)
6.3.2 North America Facial Injectables Revenue by Application (2017-2028)
6.4 North America Facial Injectables Market Size by Country
6.4.1 North America Facial Injectables Sales by Country (2017-2028)
6.4.2 North America Facial Injectables Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Facial Injectables Sales Breakdown by Company
7.1.1 Europe Facial Injectables Sales by Company (2017-2022)
7.1.2 Europe Facial Injectables Revenue by Company (2017-2022)
7.2 Europe Facial Injectables Market Size by Type
7.2.1 Europe Facial Injectables Sales by Type (2017-2028)
7.2.2 Europe Facial Injectables Revenue by Type (2017-2028)
7.3 Europe Facial Injectables Market Size by Application
7.3.1 Europe Facial Injectables Sales by Application (2017-2028)
7.3.2 Europe Facial Injectables Revenue by Application (2017-2028)
7.4 Europe Facial Injectables Market Size by Country
7.4.1 Europe Facial Injectables Sales by Country (2017-2028)
7.4.2 Europe Facial Injectables Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Facial Injectables Sales Breakdown by Company
8.1.1 Asia Pacific Facial Injectables Sales by Company (2017-2022)
8.1.2 Asia Pacific Facial Injectables Revenue by Company (2017-2022)
8.2 Asia Pacific Facial Injectables Market Size by Type
8.2.1 Asia Pacific Facial Injectables Sales by Type (2017-2028)
8.2.2 Asia Pacific Facial Injectables Revenue by Type (2017-2028)
8.3 Asia Pacific Facial Injectables Market Size by Application
8.3.1 Asia Pacific Facial Injectables Sales by Application (2017-2028)
8.3.2 Asia Pacific Facial Injectables Revenue by Application (2017-2028)
8.4 Asia Pacific Facial Injectables Market Size by Region
8.4.1 Asia Pacific Facial Injectables Sales by Region
8.4.2 Asia Pacific Facial Injectables Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Facial Injectables Sales Breakdown by Company
9.1.1 Latin America Facial Injectables Sales by Company (2017-2022)
9.1.2 Latin America Facial Injectables Revenue by Company (2017-2022)
9.2 Latin America Facial Injectables Market Size by Type
9.2.1 Latin America Facial Injectables Sales by Type (2017-2028)
9.2.2 Latin America Facial Injectables Revenue by Type (2017-2028)
9.3 Latin America Facial Injectables Market Size by Application
9.3.1 Latin America Facial Injectables Sales by Application (2017-2028)
9.3.2 Latin America Facial Injectables Revenue by Application (2017-2028)
9.4 Latin America Facial Injectables Market Size by Country
9.4.1 Latin America Facial Injectables Sales by Country (2017-2028)
9.4.2 Latin America Facial Injectables Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Facial Injectables Sales Breakdown by Company
10.1.1 Middle East and Africa Facial Injectables Sales by Company (2017-2022)
10.1.2 Middle East and Africa Facial Injectables Revenue by Company (2017-2022)
10.2 Middle East and Africa Facial Injectables Market Size by Type
10.2.1 Middle East and Africa Facial Injectables Sales by Type (2017-2028)
10.2.2 Middle East and Africa Facial Injectables Revenue by Type (2017-2028)
10.3 Middle East and Africa Facial Injectables Market Size by Application
10.3.1 Middle East and Africa Facial Injectables Sales by Application (2017-2028)
10.3.2 Middle East and Africa Facial Injectables Revenue by Application (2017-2028)
10.4 Middle East and Africa Facial Injectables Market Size by Country
10.4.1 Middle East and Africa Facial Injectables Sales by Country (2017-2028)
10.4.2 Middle East and Africa Facial Injectables Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Overview
11.1.3 Allergan Facial Injectables Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Allergan Facial Injectables Products and Services
11.1.5 Allergan Facial Injectables SWOT Analysis
11.1.6 Allergan Recent Developments
11.2 Merz Aesthetics
11.2.1 Merz Aesthetics Corporation Information
11.2.2 Merz Aesthetics Overview
11.2.3 Merz Aesthetics Facial Injectables Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Merz Aesthetics Facial Injectables Products and Services
11.2.5 Merz Aesthetics Facial Injectables SWOT Analysis
11.2.6 Merz Aesthetics Recent Developments
11.3 Prollenium Medical Technologies
11.3.1 Prollenium Medical Technologies Corporation Information
11.3.2 Prollenium Medical Technologies Overview
11.3.3 Prollenium Medical Technologies Facial Injectables Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Prollenium Medical Technologies Facial Injectables Products and Services
11.3.5 Prollenium Medical Technologies Facial Injectables SWOT Analysis
11.3.6 Prollenium Medical Technologies Recent Developments
11.4 Bloomega BioTechnology
11.4.1 Bloomega BioTechnology Corporation Information
11.4.2 Bloomega BioTechnology Overview
11.4.3 Bloomega BioTechnology Facial Injectables Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Bloomega BioTechnology Facial Injectables Products and Services
11.4.5 Bloomega BioTechnology Facial Injectables SWOT Analysis
11.4.6 Bloomega BioTechnology Recent Developments
11.5 Galderma
11.5.1 Galderma Corporation Information
11.5.2 Galderma Overview
11.5.3 Galderma Facial Injectables Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Galderma Facial Injectables Products and Services
11.5.5 Galderma Facial Injectables SWOT Analysis
11.5.6 Galderma Recent Developments
11.6 Ipsen Group
11.6.1 Ipsen Group Corporation Information
11.6.2 Ipsen Group Overview
11.6.3 Ipsen Group Facial Injectables Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Ipsen Group Facial Injectables Products and Services
11.6.5 Ipsen Group Facial Injectables SWOT Analysis
11.6.6 Ipsen Group Recent Developments
11.7 Suneva Medical
11.7.1 Suneva Medical Corporation Information
11.7.2 Suneva Medical Overview
11.7.3 Suneva Medical Facial Injectables Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Suneva Medical Facial Injectables Products and Services
11.7.5 Suneva Medical Facial Injectables SWOT Analysis
11.7.6 Suneva Medical Recent Developments
11.8 Polymekon
11.8.1 Polymekon Corporation Information
11.8.2 Polymekon Overview
11.8.3 Polymekon Facial Injectables Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Polymekon Facial Injectables Products and Services
11.8.5 Polymekon Facial Injectables SWOT Analysis
11.8.6 Polymekon Recent Developments
11.9 Visionmed
11.9.1 Visionmed Corporation Information
11.9.2 Visionmed Overview
11.9.3 Visionmed Facial Injectables Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 Visionmed Facial Injectables Products and Services
11.9.5 Visionmed Facial Injectables SWOT Analysis
11.9.6 Visionmed Recent Developments
11.10 Syneron
11.10.1 Syneron Corporation Information
11.10.2 Syneron Overview
11.10.3 Syneron Facial Injectables Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 Syneron Facial Injectables Products and Services
11.10.5 Syneron Facial Injectables SWOT Analysis
11.10.6 Syneron Recent Developments
11.11 Medytox
11.11.1 Medytox Corporation Information
11.11.2 Medytox Overview
11.11.3 Medytox Facial Injectables Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.11.4 Medytox Facial Injectables Products and Services
11.11.5 Medytox Recent Developments
11.12 AQTIS Medical
11.12.1 AQTIS Medical Corporation Information
11.12.2 AQTIS Medical Overview
11.12.3 AQTIS Medical Facial Injectables Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.12.4 AQTIS Medical Facial Injectables Products and Services
11.12.5 AQTIS Medical Recent Developments
11.13 ColBar LifeScience
11.13.1 ColBar LifeScience Corporation Information
11.13.2 ColBar LifeScience Overview
11.13.3 ColBar LifeScience Facial Injectables Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.13.4 ColBar LifeScience Facial Injectables Products and Services
11.13.5 ColBar LifeScience Recent Developments
11.14 SciVision Biotech
11.14.1 SciVision Biotech Corporation Information
11.14.2 SciVision Biotech Overview
11.14.3 SciVision Biotech Facial Injectables Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.14.4 SciVision Biotech Facial Injectables Products and Services
11.14.5 SciVision Biotech Recent Developments
11.15 Hangzhou Techderm Biological Products
11.15.1 Hangzhou Techderm Biological Products Corporation Information
11.15.2 Hangzhou Techderm Biological Products Overview
11.15.3 Hangzhou Techderm Biological Products Facial Injectables Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.15.4 Hangzhou Techderm Biological Products Facial Injectables Products and Services
11.15.5 Hangzhou Techderm Biological Products Recent Developments
11.16 Qufu Guanglong Biochem
11.16.1 Qufu Guanglong Biochem Corporation Information
11.16.2 Qufu Guanglong Biochem Overview
11.16.3 Qufu Guanglong Biochem Facial Injectables Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.16.4 Qufu Guanglong Biochem Facial Injectables Products and Services
11.16.5 Qufu Guanglong Biochem Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Facial Injectables Value Chain Analysis
12.2 Facial Injectables Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Facial Injectables Production Mode & Process
12.4 Facial Injectables Sales and Marketing
12.4.1 Facial Injectables Sales Channels
12.4.2 Facial Injectables Distributors
12.5 Facial Injectables Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Figures, Tables and Charts Available in Global Facial Injectables Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
List of TablesTable 1. Global Facial Injectables Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Botox
Table 3. Major Manufacturers of Dermal Fillers
Table 4. Major Manufacturers of Other
Table 5. Global Facial Injectables Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Facial Injectables Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 7. Global Facial Injectables Sales by Region (2017-2022) & (K Pcs)
Table 8. Global Facial Injectables Sales Market Share by Region (2017-2022)
Table 9. Global Facial Injectables Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Facial Injectables Revenue Market Share by Region (2017-2022)
Table 11. Global Facial Injectables Sales Forecast by Region (2023-2028) & (K Pcs)
Table 12. Global Facial Injectables Sales Market Share Forecast by Region (2023-2028)
Table 13. Global Facial Injectables Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 14. Global Facial Injectables Revenue Market Share Forecast by Region (2023-2028)
Table 15. Top Facial Injectables Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 16. Facial Injectables Market Trends
Table 17. Facial Injectables Market Drivers
Table 18. Facial Injectables Market Challenges
Table 19. Facial Injectables Market Restraints
Table 20. Global Facial Injectables Sales by Manufacturers (2017-2022) & (K Pcs)
Table 21. Global Facial Injectables Sales Share by Manufacturers (2017-2022)
Table 22. Global Facial Injectables Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 23. Ranking of Global Top Facial Injectables Manufacturers by Revenue (US$ Million) in 2021
Table 24. Facial Injectables Revenue Share by Manufacturers (2017-2022)
Table 25. Global Facial Injectables Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Facial Injectables as of 2021)
Table 27. Key Manufacturers Facial Injectables Average Selling Price (ASP) & (2017-2022) & (USD/Pcs)
Table 28. Key Manufacturers Facial Injectables Plants/Factories Distribution
Table 29. Key Manufacturers Facial Injectables Area Served
Table 30. Date of Key Manufacturers Enter into Facial Injectables Market
Table 31. Key Manufacturers Facial Injectables Product Type
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Facial Injectables Sales (K Pcs) by Type (2017-2022)
Table 34. Global Facial Injectables Sales Share by Type (2017-2022)
Table 35. Global Facial Injectables Revenue (US$ Million) Market Share by Type (2017-2022)
Table 36. Global Facial Injectables Price (K Pcs) by Type (2017-2022)
Table 37. Global Facial Injectables Sales (K Pcs) by Type (2023-2028)
Table 38. Global Facial Injectables Sales Share by Type (2023-2028)
Table 39. Global Facial Injectables Revenue (US$ Million) Market Share by Type (2023-2028)
Table 40. Global Facial Injectables Revenue Share by Type (2023-2028)
Table 41. Global Facial Injectables Price (K Pcs) by Type (2023-2028)
Table 42. Global Facial Injectables Sales (K Pcs) by Application (2017-2022)
Table 43. Global Facial Injectables Sales Share by Application (2017-2022)
Table 44. Global Facial Injectables Revenue (US$ Million) Market Share by Application (2017-2022)
Table 45. Global Facial Injectables Price (K Pcs) by Application (2017-2022)
Table 46. Global Facial Injectables Sales (K Pcs) by Application (2023-2028)
Table 47. Global Facial Injectables Sales Share by Application (2023-2028)
Table 48. Global Facial Injectables Revenue (US$ Million) Market Share by Application (2023-2028)
Table 49. Global Facial Injectables Revenue Share by Application (2023-2028)
Table 50. Global Facial Injectables Price (K Pcs) by Application (2023-2028)
Table 51. North America Facial Injectables Sales by Company (2017-2022) & (K Pcs)
Table 52. North America Facial Injectables Sales Market Share by Company (2017-2022)
Table 53. North America Facial Injectables Revenue by Company (2017-2022) & (US$ Million)
Table 54. North America Facial Injectables Revenue Market Share by Company (2017-2022)
Table 55. North America Facial Injectables Sales by Type (2017-2022) & (K Pcs)
Table 56. North America Facial Injectables Sales by Type (2023-2028) & (K Pcs)
Table 57. North America Facial Injectables Revenue by Type (2017-2022) & (US$ Million)
Table 58. North America Facial Injectables Revenue by Type (2023-2028) & (US$ Million)
Table 59. North America Facial Injectables Sales by Application (2017-2022) & (K Pcs)
Table 60. North America Facial Injectables Sales by Application (2023-2028) & (K Pcs)
Table 61. North America Facial Injectables Revenue by Application (2017-2022) & (US$ Million)
Table 62. North America Facial Injectables Revenue by Application (2023-2028) & (US$ Million)
Table 63. North America Facial Injectables Sales by Country (2017-2022) & (K Pcs)
Table 64. North America Facial Injectables Sales by Country (2023-2028) & (K Pcs)
Table 65. North America Facial Injectables Revenue by Country (2017-2022) & (US$ Million)
Table 66. North America Facial Injectables Revenue by Country (2023-2028) & (US$ Million)
Table 67. Europe Facial Injectables Sales by Company (2017-2022) & (K Pcs)
Table 68. Europe Facial Injectables Sales Market Share by Company (2017-2022)
Table 69. Europe Facial Injectables Revenue by Company (2017-2022) & (US$ Million)
Table 70. Europe Facial Injectables Revenue Market Share by Company (2017-2022)
Table 71. Europe Facial Injectables Sales by Type (2017-2022) & (K Pcs)
Table 72. Europe Facial Injectables Sales by Type (2023-2028) & (K Pcs)
Table 73. Europe Facial Injectables Revenue by Type (2017-2022) & (US$ Million)
Table 74. Europe Facial Injectables Revenue by Type (2023-2028) & (US$ Million)
Table 75. Europe Facial Injectables Sales by Application (2017-2022) & (K Pcs)
Table 76. Europe Facial Injectables Sales by Application (2023-2028) & (K Pcs)
Table 77. Europe Facial Injectables Revenue by Application (2017-2022) & (US$ Million)
Table 78. Europe Facial Injectables Revenue by Application (2023-2028) & (US$ Million)
Table 79. Europe Facial Injectables Sales by Country (2017-2022) & (K Pcs)
Table 80. Europe Facial Injectables Sales by Country (2023-2028) & (K Pcs)
Table 81. Europe Facial Injectables Revenue by Country (2017-2022) & (US$ Million)
Table 82. Europe Facial Injectables Revenue by Country (2023-2028) & (US$ Million)
Table 83. Asia Pacific Facial Injectables Sales by Company (2017-2022) & (K Pcs)
Table 84. Asia Pacific Facial Injectables Sales Market Share by Company (2017-2022)
Table 85. Asia Pacific Facial Injectables Revenue by Company (2017-2022) & (US$ Million)
Table 86. Asia Pacific Facial Injectables Revenue Market Share by Company (2017-2022)
Table 87. Asia Pacific Facial Injectables Sales by Type (2017-2022) & (K Pcs)
Table 88. Asia Pacific Facial Injectables Sales by Type (2023-2028) & (K Pcs)
Table 89. Asia Pacific Facial Injectables Revenue by Type (2017-2022) & (US$ Million)
Table 90. Asia Pacific Facial Injectables Revenue by Type (2023-2028) & (US$ Million)
Table 91. Asia Pacific Facial Injectables Sales by Application (2017-2022) & (K Pcs)
Table 92. Asia Pacific Facial Injectables Sales by Application (2023-2028) & (K Pcs)
Table 93. Asia Pacific Facial Injectables Revenue by Application (2017-2022) & (US$ Million)
Table 94. Asia Pacific Facial Injectables Revenue by Application (2023-2028) & (US$ Million)
Table 95. Asia Pacific Facial Injectables Sales by Region (2017-2022) & (K Pcs)
Table 96. Asia Pacific Facial Injectables Sales by Region (2023-2028) & (K Pcs)
Table 97. Asia Pacific Facial Injectables Revenue by Region (2017-2022) & (US$ Million)
Table 98. Asia Pacific Facial Injectables Revenue by Region (2023-2028) & (US$ Million)
Table 99. Latin America Facial Injectables Sales by Company (2017-2022) & (K Pcs)
Table 100. Latin America Facial Injectables Sales Market Share by Company (2017-2022)
Table 101. Latin America Facial Injectables Revenue by Company (2017-2022) & (US$ Million)
Table 102. Latin America Facial Injectables Revenue Market Share by Company (2017-2022)
Table 103. Latin America Facial Injectables Sales by Type (2017-2022) & (K Pcs)
Table 104. Latin America Facial Injectables Sales by Type (2023-2028) & (K Pcs)
Table 105. Latin America Facial Injectables Revenue by Type (2017-2022) & (US$ Million)
Table 106. Latin America Facial Injectables Revenue by Type (2023-2028) & (US$ Million)
Table 107. Latin America Facial Injectables Sales by Application (2017-2022) & (K Pcs)
Table 108. Latin America Facial Injectables Sales by Application (2023-2028) & (K Pcs)
Table 109. Latin America Facial Injectables Revenue by Application (2017-2022) & (US$ Million)
Table 110. Latin America Facial Injectables Revenue by Application (2023-2028) & (US$ Million)
Table 111. Latin America Facial Injectables Sales by Country (2017-2022) & (K Pcs)
Table 112. Latin America Facial Injectables Sales by Country (2023-2028) & (K Pcs)
Table 113. Latin America Facial Injectables Revenue by Country (2017-2022) & (US$ Million)
Table 114. Latin America Facial Injectables Revenue by Country (2023-2028) & (US$ Million)
Table 115. Middle East and Africa Facial Injectables Sales by Company (2017-2022) & (K Pcs)
Table 116. Middle East and Africa Facial Injectables Sales Market Share by Company (2017-2022)
Table 117. Middle East and Africa Facial Injectables Revenue by Company (2017-2022) & (US$ Million)
Table 118. Middle East and Africa Facial Injectables Revenue Market Share by Company (2017-2022)
Table 119. Middle East and Africa Facial Injectables Sales by Type (2017-2022) & (K Pcs)
Table 120. Middle East and Africa Facial Injectables Sales by Type (2023-2028) & (K Pcs)
Table 121. Middle East and Africa Facial Injectables Revenue by Type (2017-2022) & (US$ Million)
Table 122. Middle East and Africa Facial Injectables Revenue by Type (2023-2028) & (US$ Million)
Table 123. Middle East and Africa Facial Injectables Sales by Application (2017-2022) & (K Pcs)
Table 124. Middle East and Africa Facial Injectables Sales by Application (2023-2028) & (K Pcs)
Table 125. Middle East and Africa Facial Injectables Revenue by Application (2017-2022) & (US$ Million)
Table 126. Middle East and Africa Facial Injectables Revenue by Application (2023-2028) & (US$ Million)
Table 127. Middle East and Africa Facial Injectables Sales by Country (2017-2022) & (K Pcs)
Table 128. Middle East and Africa Facial Injectables Sales by Country (2023-2028) & (K Pcs)
Table 129. Middle East and Africa Facial Injectables Revenue by Country (2017-2022) & (US$ Million)
Table 130. Middle East and Africa Facial Injectables Revenue by Country (2023-2028) & (US$ Million)
Table 131. Allergan Corporation Information
Table 132. Allergan Description and Overview
Table 133. Allergan Facial Injectables Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 134. Allergan Facial Injectables Product and Services
Table 135. Allergan Facial Injectables SWOT Analysis
Table 136. Allergan Recent Developments
Table 137. Merz Aesthetics Corporation Information
Table 138. Merz Aesthetics Description and Overview
Table 139. Merz Aesthetics Facial Injectables Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 140. Merz Aesthetics Facial Injectables Product and Services
Table 141. Merz Aesthetics Facial Injectables SWOT Analysis
Table 142. Merz Aesthetics Recent Developments
Table 143. Prollenium Medical Technologies Corporation Information
Table 144. Prollenium Medical Technologies Description and Overview
Table 145. Prollenium Medical Technologies Facial Injectables Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 146. Prollenium Medical Technologies Facial Injectables Product and Services
Table 147. Prollenium Medical Technologies Facial Injectables SWOT Analysis
Table 148. Prollenium Medical Technologies Recent Developments
Table 149. Bloomega BioTechnology Corporation Information
Table 150. Bloomega BioTechnology Description and Overview
Table 151. Bloomega BioTechnology Facial Injectables Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 152. Bloomega BioTechnology Facial Injectables Product and Services
Table 153. Bloomega BioTechnology Facial Injectables SWOT Analysis
Table 154. Bloomega BioTechnology Recent Developments
Table 155. Galderma Corporation Information
Table 156. Galderma Description and Overview
Table 157. Galderma Facial Injectables Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 158. Galderma Facial Injectables Product and Services
Table 159. Galderma Facial Injectables SWOT Analysis
Table 160. Galderma Recent Developments
Table 161. Ipsen Group Corporation Information
Table 162. Ipsen Group Description and Overview
Table 163. Ipsen Group Facial Injectables Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 164. Ipsen Group Facial Injectables Product and Services
Table 165. Ipsen Group Facial Injectables SWOT Analysis
Table 166. Ipsen Group Recent Developments
Table 167. Suneva Medical Corporation Information
Table 168. Suneva Medical Description and Overview
Table 169. Suneva Medical Facial Injectables Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 170. Suneva Medical Facial Injectables Product and Services
Table 171. Suneva Medical Facial Injectables SWOT Analysis
Table 172. Suneva Medical Recent Developments
Table 173. Polymekon Corporation Information
Table 174. Polymekon Description and Overview
Table 175. Polymekon Facial Injectables Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 176. Polymekon Facial Injectables Product and Services
Table 177. Polymekon Facial Injectables SWOT Analysis
Table 178. Polymekon Recent Developments
Table 179. Visionmed Corporation Information
Table 180. Visionmed Description and Overview
Table 181. Visionmed Facial Injectables Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 182. Visionmed Facial Injectables Product and Services
Table 183. Visionmed Facial Injectables SWOT Analysis
Table 184. Visionmed Recent Developments
Table 185. Syneron Corporation Information
Table 186. Syneron Description and Overview
Table 187. Syneron Facial Injectables Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 188. Syneron Facial Injectables Product and Services
Table 189. Syneron Facial Injectables SWOT Analysis
Table 190. Syneron Recent Developments
Table 191. Medytox Corporation Information
Table 192. Medytox Description and Overview
Table 193. Medytox Facial Injectables Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 194. Medytox Facial Injectables Product and Services
Table 195. Medytox Recent Developments
Table 196. AQTIS Medical Corporation Information
Table 197. AQTIS Medical Description and Overview
Table 198. AQTIS Medical Facial Injectables Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 199. AQTIS Medical Facial Injectables Product and Services
Table 200. AQTIS Medical Recent Developments
Table 201. ColBar LifeScience Corporation Information
Table 202. ColBar LifeScience Description and Overview
Table 203. ColBar LifeScience Facial Injectables Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 204. ColBar LifeScience Facial Injectables Product and Services
Table 205. ColBar LifeScience Recent Developments
Table 206. SciVision Biotech Corporation Information
Table 207. SciVision Biotech Description and Overview
Table 208. SciVision Biotech Facial Injectables Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 209. SciVision Biotech Facial Injectables Product and Services
Table 210. SciVision Biotech Recent Developments
Table 211. Hangzhou Techderm Biological Products Corporation Information
Table 212. Hangzhou Techderm Biological Products Description and Overview
Table 213. Hangzhou Techderm Biological Products Facial Injectables Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 214. Hangzhou Techderm Biological Products Facial Injectables Product and Services
Table 215. Hangzhou Techderm Biological Products Recent Developments
Table 216. Qufu Guanglong Biochem Corporation Information
Table 217. Qufu Guanglong Biochem Description and Overview
Table 218. Qufu Guanglong Biochem Facial Injectables Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 219. Qufu Guanglong Biochem Facial Injectables Product and Services
Table 220. Qufu Guanglong Biochem Recent Developments
Table 221. Key Raw Materials Lists
Table 222. Raw Materials Key Suppliers Lists
Table 223. Facial Injectables Distributors List
Table 224. Facial Injectables Customers List
Table 225. Research Programs/Design for This Report
Table 226. Key Data Information from Secondary Sources
Table 227. Key Data Information from Primary Sources
List of Figures
Figure 1. Facial Injectables Product Picture
Figure 2. Global Facial Injectables Sales Market Share by Type in 2021 & 2028
Figure 3. Botox Product Picture
Figure 4. Dermal Fillers Product Picture
Figure 5. Other Product Picture
Figure 6. Global Facial Injectables Sales Market Share by Application in 2021 & 2028
Figure 7. Hospitals Use Case
Figure 8. Clinics Use Case
Figure 9. Cosmetic Centers Use Case
Figure 10. Other Use Case
Figure 11. Facial Injectables Report Years Considered
Figure 12. Global Facial Injectables Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Facial Injectables Market Size 2017-2028 (US$ Million)
Figure 14. Global Facial Injectables Sales (2017-2022) & (K Pcs)
Figure 15. Global Facial Injectables Market Size Market Share by Region: 2021 VS 2028
Figure 16. Global Facial Injectables Sales Market Share by Region (2017-2022)
Figure 17. Global Facial Injectables Sales Market Share by Region in 2021
Figure 18. Global Facial Injectables Revenue Market Share by Region in 2017 VS 2021
Figure 19. Global Facial Injectables Sales Share by Manufacturers in 2021
Figure 20. The 5 and 10 Largest Manufacturers in the World: Market Share by Facial Injectables Sales in 2021
Figure 21. Facial Injectables Revenue Share by Manufacturers in 2021
Figure 22. Facial Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 23. Global Facial Injectables Revenue Share by Type (2017-2022)
Figure 24. Global Facial Injectables Revenue Growth Rate by Type in 2017 & 2021
Figure 25. Global Facial Injectables Revenue Share by Application (2017-2022)
Figure 26. Global Facial Injectables Revenue Growth Rate by Application in 2017 & 2021
Figure 27. North America Facial Injectables Sales Market Share by Type (2017-2028)
Figure 28. North America Facial Injectables Revenue Market Share by Type (2017-2028)
Figure 29. North America Facial Injectables Sales Market Share by Application (2017-2028)
Figure 30. North America Facial Injectables Revenue Market Share by Application (2017-2028)
Figure 31. North America Facial Injectables Sales Share by Country (2017-2028)
Figure 32. North America Facial Injectables Revenue Share by Country (2017-2028)
Figure 33. U.S. Facial Injectables Revenue (2017-2028) & (US$ Million)
Figure 34. Canada Facial Injectables Revenue (2017-2028) & (US$ Million)
Figure 35. Europe Facial Injectables Sales Market Share by Type (2017-2028)
Figure 36. Europe Facial Injectables Revenue Market Share by Type (2017-2028)
Figure 37. Europe Facial Injectables Sales Market Share by Application (2017-2028)
Figure 38. Europe Facial Injectables Revenue Market Share by Application (2017-2028)
Figure 39. Europe Facial Injectables Sales Share by Country (2017-2028)
Figure 40. Europe Facial Injectables Revenue Share by Country (2017-2028)
Figure 41. Germany Facial Injectables Revenue (2017-2028) & (US$ Million)
Figure 42. France Facial Injectables Revenue (2017-2028) & (US$ Million)
Figure 43. U.K. Facial Injectables Revenue (2017-2028) & (US$ Million)
Figure 44. Italy Facial Injectables Revenue (2017-2028) & (US$ Million)
Figure 45. Russia Facial Injectables Revenue (2017-2028) & (US$ Million)
Figure 46. Asia Pacific Facial Injectables Sales Market Share by Type (2017-2028)
Figure 47. Asia Pacific Facial Injectables Revenue Market Share by Type (2017-2028)
Figure 48. Asia Pacific Facial Injectables Sales Market Share by Application (2017-2028)
Figure 49. Asia Pacific Facial Injectables Revenue Market Share by Application (2017-2028)
Figure 50. Asia Pacific Facial Injectables Sales Share by Region (2017-2028)
Figure 51. Asia Pacific Facial Injectables Revenue Share by Region (2017-2028)
Figure 52. China Facial Injectables Revenue (2017-2028) & (US$ Million)
Figure 53. Japan Facial Injectables Revenue (2017-2028) & (US$ Million)
Figure 54. South Korea Facial Injectables Revenue (2017-2028) & (US$ Million)
Figure 55. India Facial Injectables Revenue (2017-2028) & (US$ Million)
Figure 56. Australia Facial Injectables Revenue (2017-2028) & (US$ Million)
Figure 57. Taiwan Facial Injectables Revenue (2017-2028) & (US$ Million)
Figure 58. Indonesia Facial Injectables Revenue (2017-2028) & (US$ Million)
Figure 59. Thailand Facial Injectables Revenue (2017-2028) & (US$ Million)
Figure 60. Malaysia Facial Injectables Revenue (2017-2028) & (US$ Million)
Figure 61. Philippines Facial Injectables Revenue (2017-2028) & (US$ Million)
Figure 62. Vietnam Facial Injectables Revenue (2017-2028) & (US$ Million)
Figure 63. Latin America Facial Injectables Sales Market Share by Type (2017-2028)
Figure 64. Latin America Facial Injectables Revenue Market Share by Type (2017-2028)
Figure 65. Latin America Facial Injectables Sales Market Share by Application (2017-2028)
Figure 66. Latin America Facial Injectables Revenue Market Share by Application (2017-2028)
Figure 67. Latin America Facial Injectables Sales Share by Country (2017-2028)
Figure 68. Latin America Facial Injectables Revenue Share by Country (2017-2028)
Figure 69. Mexico Facial Injectables Revenue (2017-2028) & (US$ Million)
Figure 70. Brazil Facial Injectables Revenue (2017-2028) & (US$ Million)
Figure 71. Argentina Facial Injectables Revenue (2017-2028) & (US$ Million)
Figure 72. Middle East and Africa Facial Injectables Sales Market Share by Type (2017-2028)
Figure 73. Middle East and Africa Facial Injectables Revenue Market Share by Type (2017-2028)
Figure 74. Middle East and Africa Facial Injectables Sales Market Share by Application (2017-2028)
Figure 75. Middle East and Africa Facial Injectables Revenue Market Share by Application (2017-2028)
Figure 76. Middle East and Africa Facial Injectables Sales Share by Country (2017-2028)
Figure 77. Middle East and Africa Facial Injectables Revenue Share by Country (2017-2028)
Figure 78. Turkey Facial Injectables Revenue (2017-2028) & (US$ Million)
Figure 79. Saudi Arabia Facial Injectables Revenue (2017-2028) & (US$ Million)
Figure 80. UAE Facial Injectables Revenue (2017-2028) & (US$ Million)
Figure 81. Facial Injectables Value Chain
Figure 82. Facial Injectables Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
Keyplayers in Global Facial Injectables Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
AllerganMerz Aesthetics
Prollenium Medical Technologies
Bloomega BioTechnology
Galderma
Ipsen Group
Suneva Medical
Polymekon
Visionmed
Syneron
Medytox
AQTIS Medical
ColBar LifeScience
SciVision Biotech
Hangzhou Techderm Biological Products
Qufu Guanglong Biochem
REQUEST TABLES & FIGURES MENTIONED IN THIS REPORT
